Literature DB >> 19833625

Eosinophilia and thrombosis in parasitic diseases: an overview.

Paul R J Ames1, Giuseppina Aloj, Fabrizio Gentile.   

Abstract

It is known that peripheral blood eosinophilia (PBE) is a normal hematopoietic response to several parasitic diseases, but it is less known that PBE promotes a hypercoagulable state that may favor thrombosis. Scope of this article is to explore which parasitic infestations are most likely to be complicated by thrombosis and to highlight the pathogenetic contribution of PBE to vascular occlusions in this setting. A review of the world literature revealed 18 cases in which PBE was associated with vascular occlusion though no specific surveys were dedicated to this topic. The eosinophil exerts its thrombogenic potential by inhibition of the natural anticoagulant pathways and release of tissue factor with enhanced coagulation activation leading to vascular occlusion. It is hoped that this review contributes to the awareness of the link between PBE and thrombosis in parasitic disorders to foster research in this area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833625     DOI: 10.1177/1076029609348314

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  9 in total

1.  Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps.

Authors:  Charlotte Marx; Julia Novotny; Danby Salbeck; Katie R Zellner; Leo Nicolai; Kami Pekayvaz; Badr Kilani; Sven Stockhausen; Niklas Bürgener; Danny Kupka; Thomas J Stocker; Ludwig T Weckbach; Joachim Pircher; Markus Moser; Michael Joner; Walter Desmet; Tom Adriaenssens; Franz-Josef Neumann; Anthony H Gerschlick; Jurrien M Ten Berg; Michael Lorenz; Konstantin Stark
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

2.  Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events.

Authors:  Mara Waters; Sigmund Krajden; Christie Kim; Reem Elsobky; Bohdan Lychacz; Matthew Cheung; Mark Crowther; Jay Keystone
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

Review 3.  Management of hypereosinophilia in tropical settings.

Authors:  Arjun Datt Law; Subhash Chander Varma
Journal:  Med J Armed Forces India       Date:  2014-12-25

4.  Significance of eosinophil accumulation in the thrombus and decrease in peripheral blood in patients with acute coronary syndrome.

Authors:  Ping Jiang; De-zhao Wang; Ya-li Ren; Jian-ping Cai; Bu-xing Chen
Journal:  Coron Artery Dis       Date:  2015-03       Impact factor: 1.439

5.  Staphylococcus aureus Endocarditis as a Complication of Toxocariasis-Associated Endomyocarditis With Fibrosis: A Case Report.

Authors:  Esther Kuenzli; Niklaus Labhardt; Gianmarco Balestra; Maja Weisser; Michael J Zellweger; Johannes Blum
Journal:  Open Forum Infect Dis       Date:  2016-09-07       Impact factor: 3.835

6.  Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Liu Ye; Hong-Mei Bai; Dan Jiang; Bing He; Xue-Song Wen; Ping Ge; Dong-Ying Zhang
Journal:  J Clin Lab Anal       Date:  2020-05-22       Impact factor: 2.352

7.  Portal vein thrombosis and food protein-induced allergic proctocolitis in a premature newborn with hypereosinophilia: a case report.

Authors:  Cheong-Jun Moon; Tae Hee Kwon; Hyun-Seung Lee
Journal:  BMC Pediatr       Date:  2021-01-23       Impact factor: 2.125

8.  Impacts of eosinophil percentage on prognosis acute type A aortic dissection patients.

Authors:  Yue Shao; Liu Ye; Hao-Ming Shi; Xin-Mei Wang; Jun Luo; Lu Liu; Qing-Chen Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-04-02       Impact factor: 2.298

9.  The role of peripheral blood eosinophil counts in acute Stanford type A aortic dissection patients.

Authors:  Xichun Qin; Yaxuan Gao; Yi Jiang; Feng Zhu; Wei Xie; Xinlong Tang; Yunxing Xue; Dongjin Wang; Hailong Cao
Journal:  Front Surg       Date:  2022-08-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.